Latest Listings And Ipos News

Pacific Edge has secured final Medicare coverage for Cxbladder Triage and Triage Plus in intermediate-risk microhematuria, with the policy due to take effect on 20 December. The decision gives the company a clearer reimbursement pathway, but revenue gains still depend on adoption and testing volumes.

Locate Technologies has arranged A$3.0 million of drawn senior debt and a A$1.0 million convertible note to repay its PURE Asset Management facility ahead of maturity. The refinancing removes the immediate repayment deadline, but leaves the company with substantial interest costs and potential equity dilution.

Southern Company delivered a stronger third quarter, with reported earnings up 19.6% and revenue rising 13% as warmer weather, customer growth and large commercial demand lifted electricity sales. The result also carries a growing list of costs tied to wind repowering, debt transactions and regulatory issues at Nicor Gas.

Iron Mountain delivered record third-quarter revenue and AFFO, raised its 2026 outlook and lifted its quarterly dividend by 15%. Data centre leasing and asset lifecycle management are driving the company’s faster-growing businesses, although expansion is demanding substantial capital.

Vistra has completed its acquisition of Cogentrix Energy, adding 10 natural gas facilities and nearly 5,500 megawatts of generation capacity across three major US power markets. The deal carries approximately US$2.2 billion in cash consideration, US$1.7 billion of assumed debt and 5 million newly issued Vistra shares.

Atlantic Lithium has secured court approval to put Huayou’s proposed acquisition to shareholders, setting a 14 December vote on the scheme. The transaction remains conditional, but the process has now moved from regulatory clearance to shareholder decision.

European Lithium has completed its takeover by Critical Metals Corp, transferring all EUR shares to the US-listed company and issuing eligible holders CRML securities. EUR is now preparing to disappear from the ASX, with the new shares expected to begin trading on Nasdaq on 6 November.

Pathkey.AI has presented Chipforge as a functioning end-to-end AI platform for chip design, backed by independent testing, benchmark comparisons and a first proof-of-value contract. The harder test now is converting that engineering progress into recurring revenue before its A$5.8 million cash balance becomes a constraint.

Neurizon says it has removed its remaining Obsidian convertible notes while targeting $6.3 million in new equity ahead of the pivotal NUZ-001 ALS readout. The funding plan reduces immediate conversion uncertainty, but the proposed Share Purchase Plan and possible future facility drawdown leave execution questions open.

Crimson Australia has closed its takeover offer for Kip McGrath after securing a 93.88% relevant interest. The bidder has begun the compulsory acquisition process for the remaining shares, moving the education group toward full ownership.

Aldoro has signed an MOU that would give WILLETECH a 51% stake in the Kameelburg project company and put the Namibian rare earths project on a proposed path to commercial production. The headline RMB2 billion funding commitment remains non-binding, however, with definitive agreements, approvals and proof of financing still outstanding.

DXN has told ASX that the intended cancellation of its A$8.8 million AI high-performance computing contract was price-sensitive information. The company expects to recover about A$4.2 million for work completed and committed costs, but has removed roughly A$8.6 million from its backlog and is still negotiating the termination agreement.